Biomedical scientist graduated from the Federal University of the State of Rio de Janeiro (2014), with a master's degree in Physiology from the Federal University of Rio de Janeiro (2016), and a PhD in Infection, Inflammation and Immunity from the University of Southampton (2023) in the United Kingdom. I have experience in cellular and molecular biology techniques, with emphasis on gene editing and transcriptome analysis. I am currently working as a postdoctoral researcher in the Translational Immuno-oncology group at the Albert Einstein Israeli Hospital." (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
The role of the immune response in response to conventional cancer therapy and disease progression or recurrence has been well established for many cancers. The era of checkpoint inhibitors (anti-PD1, anti-CTLA-4, anti-PD-L1, and others) has ushered in novel therapies that aim to activate a previously inhibited anti-cancer T cell response by blocking inhibitory receptor engagement. While …
| 1 / 1 | Ongoing scholarships in Brazil |
| Associated processes | |
CV Lattes
ORCID